Boudreau Philip P

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Boudreau Philip P's trades of Abbott Laboratories's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
401.28
Quantity 2,027 +10.4%
Value US$76,567
Transaction date
Sale
Price
464.93
Quantity 20,461 +48.7%
Value US$4,746,524
Transaction date
Proposed sale
Price
312.89
Quantity 25,172
Value US$1,432,249
Transaction date
Planned sale
Price
106.00
Quantity 8,000 -34.1%
Value US$848,000
Transaction date
Proposed sale
Price
106.00
Quantity 8,000
Value US$848,000
Transaction date
Sale
Price
126.49
Quantity 8,000 -32.2%
Value US$1,011,920
Transaction date
Sale
Price
82.00
Quantity 10,600 -32.1%
Value US$869,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-27 2026-04-23
B Purchase
2,027 +10.4%
401.28
US$76,567 		2,027 +10.4% 401.28 US$76,567
2025-08-11 2025-08-08
S Sale
20,461 +48.7%
464.93
US$4,746,524 		20,461 +48.7% 464.93 US$4,746,524
2025-08-08 2025-08-08
PrS Proposed sale
25,172
312.89
US$1,432,249 		25,172 312.89 US$1,432,249
2023-06-20 2023-06-16
PlS Planned sale
8,000 -34.1%
106.00
US$848,000 		8,000 -34.1% 106.00 US$848,000
2023-06-16 2023-06-16
PrS Proposed sale
8,000
106.00
US$848,000 		8,000 106.00 US$848,000
2021-10-27 2021-10-25
S Sale
8,000 -32.2%
126.49
US$1,011,920 		8,000 -32.2% 126.49 US$1,011,920
2020-03-16 2020-03-13
S Sale
10,600 -32.1%
82.00
US$869,200 		10,600 -32.1% 82.00 US$869,200